Palmoplantar ectodermal dysplasia

From WikiMD's WELLNESSPEDIA


Palmoplantar ectodermal dysplasia
Synonyms PPE
Pronounce N/A
Specialty N/A
Symptoms Hyperkeratosis of palms and soles, nail dystrophy, alopecia
Complications Infection, pain, mobility issues
Onset Childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Clinical examination, genetic testing
Differential diagnosis Palmoplantar keratoderma, ectodermal dysplasia
Prevention Genetic counseling
Treatment Emollients, keratolytics, retinoids
Medication Topical treatments, oral retinoids
Prognosis Variable, depends on severity
Frequency Rare
Deaths N/A


Palmoplantar ectodermal dysplasia (also known as PPED) is a rare genetic disorder characterized by abnormalities in the skin on the palms of the hands and the soles of the feet, as well as other ectodermal tissues.

Symptoms and Signs[edit]

The primary symptoms of palmoplantar ectodermal dysplasia include thickened, scaly skin on the palms and soles (keratoderma), sparse hair (hypotrichosis), and abnormal nails (onychodystrophy). Other symptoms may include dental abnormalities, hearing loss, and vision problems.

Causes[edit]

Palmoplantar ectodermal dysplasia is caused by mutations in the genes that regulate the development and function of the skin and other ectodermal tissues. These mutations are usually inherited in an autosomal dominant manner, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Diagnosis[edit]

Diagnosis of palmoplantar ectodermal dysplasia is based on the clinical symptoms and confirmed by genetic testing. The testing can identify mutations in the genes associated with this condition.

Treatment[edit]

There is currently no cure for palmoplantar ectodermal dysplasia. Treatment is symptomatic and supportive, and may include skin care to manage the keratoderma, as well as dental care, hearing aids, and vision aids as needed.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.